VLA 0.00% $1.75 viralytics limited

exciting news on vla!!!

  1. 332 Posts.
    Read an article from the Business Review Magazine done on VLA regarding the success story towards developing melanoma treatment drug. The article has been posted today on Viralytics website under media and news. It reports a 100% success rate on large sample of mice and on a small human sample size. Next stage is testing of a large human sample with results expected in March. Traders do not miss out, Buy in Doom and sell in Boom, this is a winner! It is definate that its going commercial and soon we will be getting it from pharmacy shops! Very exciting times ahead.

    Enjoy reading enjoy trading!!
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.